Tareq Abadl/LinkedIn
Sep 4, 2026, 18:22
Tareq Abadl: The Clinical Meaning of C3 and C4
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
”Complement C3 vs C4 — Don’t Mix Them Up!
Confused about C3 vs C4 in Immunology?
Here’s the high-yield difference you need to remember:
- C3 is the major and central complement component.
- C4 is mainly associated with the Classical and Lectin pathways.
Clinical Pearl:
- Low C3 with normal C4 may suggest alternative pathway activation.
- Low C3 with low C4 may indicate classical pathway consumption.
ASCP / BOC Pearl:
- Don’t interpret complement levels alone.
- Always correlate C3, C4, and clinical findings.”
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 18:16How Mutant p53 Hijacks VWF Expression in Tumor Cells – JTH
-
Sep 4, 2026, 18:08Simon Kraler: Can the Adrenomedullin System Predict Cardiogenic Shock Before It Happens?
-
Sep 4, 2026, 17:56Maxime Dely: Why Every Blood Donation Matters
-
Sep 4, 2026, 17:28Shinya Goto: When Cardiovascular Risk Gets Lower, RCTs Get Harder
-
Sep 4, 2026, 16:55New Orleans Is Calling ASH26 Is Near
-
Sep 4, 2026, 16:48ESC Congress 2026 – My Top 20 Lipidology Highlights Shaping the Future of Cardiovascular Prevention – Pablo Corral
-
Sep 4, 2026, 16:38Felice Gragnano։ Turning Cardiovascular Risk Into Action
-
Sep 4, 2026, 16:30Lisa Littner: The Hidden Burden of Prior Authorization in Bleeding Disorder Care
-
Sep 4, 2026, 13:54Ahmad G. Alzahrani: A New Classification for Acute Pulmonary Embolism